<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00523263</url>
  </required_header>
  <id_info>
    <org_study_id>DaDa-trial</org_study_id>
    <nct_id>NCT00523263</nct_id>
  </id_info>
  <brief_title>Dacron vs Dardik for Fem-Pop Bypass</brief_title>
  <acronym>DaDa</acronym>
  <official_title>Heparin Bonded and Collagen Coated Polyester or Human Umbilical Vein for Femoropopliteal Bypass: a Prospective Randomised Multicentre Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Radboud University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Radboud University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Clinical trial for the comparison of long-term patency of heparin-bonded Dacron and human
      umbilical vein vascular prostheses in above-knee femoro-popliteal bypass surgery.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 1996</start_date>
  <completion_date type="Actual">April 2007</completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Primary and primary-assisted bypass patency</measure>
    <time_frame>1 - 5 yrs</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Secondary bypass patency</measure>
    <time_frame>1 - 5 yrs</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <condition>Intermittent Claudication</condition>
  <condition>Arterial Occlusive Diseases</condition>
  <condition>Atheroslerosis</condition>
  <arm_group>
    <arm_group_label>Dacron</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients receiving polyester above-knee femoro-popliteal bypass</description>
  </arm_group>
  <arm_group>
    <arm_group_label>HUV</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>patients receiving HUV femoro-popliteal bypass</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>heparin-bonded and collagen coated polyster</intervention_name>
    <description>femoro-popliteal bypass</description>
    <arm_group_label>Dacron</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Human umbilical vein femoro-popliteal bypass</intervention_name>
    <arm_group_label>HUV</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age 31 to 89

          -  intermittent claudication

          -  ABI below 0.8

        Exclusion Criteria:

          -  non elective surgery

          -  life expectancy below 2 yrs

          -  contraindication for anticoagulant therapy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>31 Years</minimum_age>
    <maximum_age>89 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>J. Adam van der Vliet, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Radboud University Medical Center Nijmegen</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Radboud UMCN, Dept Vascular Surgery</name>
      <address>
        <city>Nijmegen</city>
        <zip>6500 HB</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <reference>
    <citation>Scharn DM, Oyen WJ, Klemm PL, Verhofstad AA, van der Vliet JA. Thrombogenicity and related biological properties of heparin bonded collagen coated polyester and human umbilical vein prosthetic vascular grafts. J Surg Res. 2006 Aug;134(2):182-9. Epub 2006 Mar 20.</citation>
    <PMID>16542682</PMID>
  </reference>
  <reference>
    <citation>Scharn DM, Oyen WJ, Klemm PL, Wijnen MH, vanderVliet JA. Assessment of prosthetic vascular graft thrombogenicity using the technetium-99m labeled glycoprotein IIb/IIIa receptor antagonist DMP444 in a dog model. Cardiovasc Surg. 2002 Dec;10(6):566-9.</citation>
    <PMID>12453688</PMID>
  </reference>
  <verification_date>August 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 30, 2007</study_first_submitted>
  <study_first_submitted_qc>August 30, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 31, 2007</study_first_posted>
  <last_update_submitted>August 30, 2007</last_update_submitted>
  <last_update_submitted_qc>August 30, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 31, 2007</last_update_posted>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Intermittent Claudication</mesh_term>
    <mesh_term>Arterial Occlusive Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Calcium heparin</mesh_term>
    <mesh_term>Heparin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

